Therapeutic blockade of Foxp3 in experimental breast cancer models-Reference-Cited by-同舟云学术

Therapeutic blockade of Foxp3 in experimental breast cancer models

Published:2017-07-29 Issue:2 Volume:166 Page:393-405
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Moreno Ayala Mariela A.,Gottardo María Florencia,Imsen Mercedes,Asad Antonela S.,Bal de Kier Joffé Elisa,Casares Noelia,Lasarte Juan José,Seilicovich Adriana,Candolfi Marianela^ORCID

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Agencia Nacional de Promoción Científica y Tecnológica

Fundación Bunge y Born

Liga Argentina de Lucha contra el Cancer

Ministerio de Educacion y Ciencia de España

Fundación Ramón Areces

Departamento de Educación, Gobierno de Navarra

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-017-4414-2/fulltext.html

Reference55 articles.

1. Adris S et al (2000) Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells. Can Res 60:6696–6703

2. Arce Vargas F et al (2017) Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors. Immunity 46:577–586. doi: 10.1016/j.immuni.2017.03.013

3. Asad AS et al (2017) Viral gene therapy for breast cancer: progress and challenges. Expert Opin Biol Ther 17:945–959. doi: 10.1080/14712598.2017.1338684

4. Banerjee DK, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar KM (2006) Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108:2655–2661. doi: 10.1182/blood-2006-03-011353

5. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373–5380. doi: 10.1200/JCO.2006.05.9584

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a proteolysis targeting chimera (PROTAC) as a potent regulator of FOXP3;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice;Acta Pharmacologica Sinica;2024-07-29

3. Biological Activity of Natural and Synthetic Peptides as Anticancer Agents;International Journal of Molecular Sciences;2024-07-01

4. Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment;International Journal of Molecular Sciences;2024-06-05

5. Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena;Cell Biochemistry and Function;2024-03-29